ESR1 and breast cancer: Cell proliferation assays revealed that miR-210 overexpression enhances MCF7 cell proliferation suggesting that the prognostic potential of miR-210 may rely on its role in tumor proliferation both in untreated and tamoxifen-only treated ER-positive BC.